Add Yahoo as a preferred source to see more of our stories on Google. XCath is developing a robot-assisted approach to brain aneurysm treatment that could bring greater precision to procedures and ...

XCath announced today that it secured $30 million in its Series C financing round to support its endovascular robotic technology.

HINGHAM, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that LIBERTY was ...

HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that Harel Gadot, ...

HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced its participation in the inaugural ...

Over the past decades, the medical community has made fantastic leaps in innovation and medicine that have improved survival rates and quality of life for patients dealing with cancer, kidney disease, ...

Stereotaxis STXS recently secured FDA 510(k) clearance for GenesisX, its next-generation robotic system designed to make endovascular surgical robotics far more accessible. The approval marks a ...

BRAINTREE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT) today announced it has entered into an agreement with Emory University, which will allow the parties to evaluate and ...

HINGHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it is ...

The US Food and Drug Administration (FDA) has cleared Microbot’s LIBERTY, a single-use, remotely operated robotic system for peripheral endovascular procedures. Microbot completed the ACCESS-BVI ...